{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:37Z","timestamp":1790456317057,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hebei Natural Science Foundation","award":["H2024206126"],"award-info":[{"award-number":["H2024206126"]}]},{"name":"the S&T Program of Hebei","award":["22377701D"],"award-info":[{"award-number":["22377701D"]}]},{"name":"the 14th Five-Year Clinical Medicine Innovation Research Team Support Program of Hebei Medical University","award":["2022LCTD-A13"],"award-info":[{"award-number":["2022LCTD-A13"]}],"id":[{"id":"https:\/\/ror.org\/04eymdx19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Higher Education Graduate Innovation Funding Project of the Degree Office of the Education Department of Hebei Province","award":["CXZZBS2025107"],"award-info":[{"award-number":["CXZZBS2025107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00535-026-02459-5","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:58:45Z","timestamp":1781207925000},"page":"1419-1430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SEVs-carried ENPP1 regulates DCs\u2019 activation and inhibits the formation of tertiary lymphoid structures in gastric cancer"],"prefix":"10.1007","volume":"61","author":[{"given":"Wenbo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limian","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6852-6947","authenticated-orcid":false,"given":"Bibo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"2","key":"2459_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","volume":"45","author":"X Diao","year":"2024","unstructured":"Diao X, Guo C, Jin Y, et al. Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun. 2024;45(2):178\u201397.","journal-title":"Cancer Commun"},{"issue":"21","key":"2459_CR2","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1001\/jama.2023.19918","volume":"330","author":"J Xu","year":"2023","unstructured":"Xu J, Jiang H, Pan Y, et al. Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial. JAMA. 2023;330(21):2064\u201374.","journal-title":"JAMA"},{"key":"2459_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-pathmechdis-051222-121126","volume":"19","author":"CR Ferreira","year":"2024","unstructured":"Ferreira CR, Carpenter TO, Braddock DT. ENPP1 in Blood and bone: skeletal and soft tissue diseases induced by ENPP1 deficiency. Annu Rev Pathol Mech Dis. 2024;19:507\u201340.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"31","key":"2459_CR4","first-page":"e2401634","volume":"11","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Bao L, Gong S, et al. T Cell-Derived Apoptotic Extracellular Vesicles Hydrolyze cGAMP to alleviate radiation enteritis via surface enzyme ENPP1. Adv Sci (Weinheim, Baden-Wurttemberg, German). 2024;11(31):e2401634.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, German)"},{"issue":"5","key":"2459_CR5","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1158\/2159-8290.CD-21-0932","volume":"12","author":"B de Ruiz-Fern\u00e1ndez C\u00f3rdoba","year":"2022","unstructured":"de Ruiz-Fern\u00e1ndez C\u00f3rdoba B, Moreno H, Valencia K, et al. Tumor ENPP1 (CD203a)\/haptoglobin axis exploits myeloid-derived suppressor cells to promote post-radiotherapy local recurrence in breast Cancer. Cancer Dis. 2022;12(5):1356\u201377.","journal-title":"Cancer Dis"},{"issue":"52","key":"2459_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313693120","volume":"120","author":"S Wang","year":"2023","unstructured":"Wang S, B\u00f6hnert V, Joseph AJ, et al. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer. Proc Natl Acad Sci USA. 2023;120(52):e2313693120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"2459_CR7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119189119","volume":"119","author":"JA Carozza","year":"2022","unstructured":"Carozza JA, Cordova AF, Brown JA, et al. ENPP1\u2019s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling. Proc Natl Acad Sci USA. 2022;119(21):e2119189119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2459_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","volume":"57","author":"S Dvorkin","year":"2024","unstructured":"Dvorkin S, Cambier S, Volkman HE, Stetson DB. New frontiers in the cGAS-STING intracellular DNA-sensing pathway. Immunity. 2024;57(4):718\u201330.","journal-title":"Immunity"},{"issue":"20","key":"2459_CR9","first-page":"2308131","volume":"11","author":"Y An","year":"2024","unstructured":"An Y, Zhu J, Xie Q, et al. Tumor exosomal ENPP1 hydrolyzes cGAMP to inhibit cGASSTING signaling. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2024;11(20):2308131.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"6576","key":"2459_CR10","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science (New York, NY). 2022;375(6576):eabf9419.","journal-title":"Science (New York, NY)"},{"issue":"10","key":"2459_CR11","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","volume":"72","author":"GS Kinker","year":"2023","unstructured":"Kinker GS, Vitiello GAF, Diniz AB, et al. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas. Gut. 2023;72(10):1927\u201341.","journal-title":"Gut"},{"issue":"8","key":"2459_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 2024;42(8):1370-1385.e1379.","journal-title":"Cancer Cell"},{"issue":"4","key":"2459_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","volume":"24","author":"L Blanchard","year":"2021","unstructured":"Blanchard L, Girard JP. High endothelial venules (HEVs) in immunity, inflammation and cancer. Angiogenesis. 2021;24(4):719\u201353.","journal-title":"Angiogenesis"},{"issue":"10","key":"2459_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.","journal-title":"PLoS Med"},{"issue":"2","key":"2459_CR15","doi-asserted-by":"publisher","first-page":"e001906","DOI":"10.1136\/jitc-2020-001906","volume":"9","author":"M Chelvanambi","year":"2021","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. 2021;9(2):e001906.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"2459_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","volume":"40","author":"A Asrir","year":"2022","unstructured":"Asrir A, Tardiveau C, Coudert J, et al. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell. 2022;40(3):318-334.e319.","journal-title":"Cancer Cell"},{"issue":"7","key":"2459_CR17","doi-asserted-by":"publisher","first-page":"3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N du PercieSert","year":"2020","unstructured":"du PercieSert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 20: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):3000410.","journal-title":"PLoS Biol"},{"issue":"1","key":"2459_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12951-024-02826-5","volume":"22","author":"B Wang","year":"2024","unstructured":"Wang B, Liu W, Zhang M, et al. Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8(+) T cell exhaustion. J Nanobiotechnol. 2024;22(1):563.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"2459_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/neuonc\/noae169","volume":"27","author":"L Santos","year":"2025","unstructured":"Santos L, Tomatis F, Ferreira HRS, et al. ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in human epidermal growth factor receptor 2-positive breast cancer. Neuro Oncol. 2025;27(1):167\u201383.","journal-title":"Neuro Oncol"},{"issue":"11","key":"2459_CR20","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1158\/2159-8290.CD-22-1338","volume":"13","author":"L Zhao","year":"2023","unstructured":"Zhao L, Liu P, Mao M, et al. BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance. Cancer Discov. 2023;13(11):2448\u201369.","journal-title":"Cancer Discov"},{"issue":"23","key":"2459_CR21","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/0008-5472.CAN-23-2716","volume":"84","author":"D An","year":"2024","unstructured":"An D, Chen G, Cheng WY, et al. LT\u03b2R agonism promotes antitumor immune responses via modulation of the tumor microenvironment. Can Res. 2024;84(23):3984\u20134001.","journal-title":"Can Res"},{"issue":"1","key":"2459_CR22","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1038\/s41467-025-59874-0","volume":"16","author":"C Pu","year":"2025","unstructured":"Pu C, Cui H, Yu H, et al. Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors. Nat Commun. 2025;16(1):4793.","journal-title":"Nat Commun"},{"issue":"11","key":"2459_CR23","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"42","author":"IP MacFawn","year":"2024","unstructured":"MacFawn IP, Magnon G, Gorecki G, et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 2024;42(11):1864-1881.e1865.","journal-title":"Cancer Cell"},{"issue":"5","key":"2459_CR24","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","volume":"78","author":"K Sili\u0146a","year":"2018","unstructured":"Sili\u0146a K, Soltermann A, Attar FM, et al. Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Can Res. 2018;78(5):1308\u201320.","journal-title":"Can Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02459-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:03:05Z","timestamp":1790452985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02459-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02459-5","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest in this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All related procedures were approved by the Internal Review Board and Ethics Committee of the Fourth Affiliated Hospital of Hebei Medical University (Approval No. 2019ME0039).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors gave their consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}